MedPath
HSA Approval

DEXTROSE 5% IN SODIUM CHLORIDE 0.9% FOR INTRAVENOUS INFUSION

SIN10235P

DEXTROSE 5% IN SODIUM CHLORIDE 0.9% FOR INTRAVENOUS INFUSION

DEXTROSE 5% IN SODIUM CHLORIDE 0.9% FOR INTRAVENOUS INFUSION

October 10, 1998

JOYSON PTE. LTD.

JOYSON PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantJOYSON PTE. LTD.
Licence HolderJOYSON PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05XA03

sodium chloride

Manufacturer Information

JOYSON PTE. LTD.

EURO-MED LABORATORIES PHIL INC

Active Ingredients

DEXTROSE MONOHYDRATE

5 g/100 ml

Glucose

SODIUM CHLORIDE

900 mg/100 ml

Sodium chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEXTROSE 5% IN SODIUM CHLORIDE 0.9% FOR INTRAVENOUS INFUSION - HSA Approval | MedPath